comparemela.com

Latest Breaking News On - Personalis inc - Page 3 : comparemela.com

Liquid Biopsy Market Worth $11 3 billion | MarketsandMarkets

Liquid Biopsy Market Worth $11 3 billion | MarketsandMarkets
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Personalis (NASDAQ:PSNL) Earns Buy Rating from Analysts at Lake Street Capital

Lake Street Capital began coverage on shares of Personalis (NASDAQ:PSNL – Free Report) in a report released on Tuesday, Benzinga reports. The brokerage issued a buy rating and a $4.00 price target on the stock. Separately, Needham & Company LLC reissued a buy rating and issued a $3.50 price objective on shares of Personalis in […]

Lake Street Capital Begins Coverage on Personalis (NASDAQ:PSNL)

Lake Street Capital initiated coverage on shares of Personalis (NASDAQ:PSNL – Free Report) in a report published on Tuesday, Benzinga reports. The firm issued a buy rating and a $4.00 price objective on the stock. Separately, Needham & Company LLC restated a buy rating and set a $3.50 price objective on shares of Personalis in […]

Personalis (NASDAQ:PSNL) Coverage Initiated at Lake Street Capital

Research analysts at Lake Street Capital initiated coverage on shares of Personalis (NASDAQ:PSNL – Get Free Report) in a research report issued on Tuesday, Benzinga reports. The brokerage set a “buy” rating and a $4.00 price target on the stock. Lake Street Capital’s target price would suggest a potential upside of 158.06% from the company’s […]

Head to Head Survey: Biodesix (NASDAQ:BDSX) & Personalis (NASDAQ:PSNL)

Biodesix (NASDAQ:BDSX – Get Free Report) and Personalis (NASDAQ:PSNL – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, institutional ownership, valuation, dividends, analyst recommendations, earnings and profitability. Institutional and Insider Ownership 21.0% of Biodesix shares are […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.